Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapy

Brain and Development

Volumn 14, Issue 6, 1992, Pages 371-380

  Oguni, Miyako ^a,b   Dansky, Linda ^a,b   Andermann, Eva ^a,b   Sherwin, Allan ^a,b   Andermann, Frederick ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

anticonvulsants; epilepsy; Pregnancy outcome; serum folate; teratogenicity

Indexed keywords

CARBAMAZEPINE; FOLIC ACID; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; COMPARATIVE STUDY; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; FETUS OUTCOME; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TERATOGENICITY;

EID: 0027087132     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(12)80343-3     Document Type: Article

References (53)

1. Antiepileptic drugs and pregnancy: altered utilization patterns and teratogenesis
2. Teratogenicity of anticonvulsant drugs IV: the association of clefting and epilepsy
3. Anticonvulsants and parental epilepsy in the development of birth defects
4. Major congenital malformations in the offspring of epileptic patients: genetic and environmental risk factors
5. Maternal epilepsy and birth defects: a prospective study with monitoring of plasma anticonvulsant levels during pregnancy
6. Maternal epilepsy and congenital malformations: correlation with maternal plasma anticonvulsant levels during pregnancy
7. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)
8. Teratogenicity of antiepileptic drugs: analysis of possible risk factors
9. Genetic predisposition to phenytoin-induced birth defects
10. Anticonvulsants, folate levels, and pregnancy outcome: a prospective study
11. Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures and fetal outcome
12. The course of epilepsy during pregnancy: a study of 78 cases
13. Outcome of pregnancy in epileptic women
14. A multivariate analysis of risk factors for major congenital malformations in offspring of epileptic women (abstr)
15. Chronic toxicity in epileptic patients receiving single-drug treatment
16. The use of blood levels of antiepileptic drugs in clinical practice
17. Interpretation of drug levels: relevance of protein binding
18. The anterior body wall
19. The foot
20. Genetics of common disorders
21. Cleft Up
22. Cleft palate
23. The hip
24. Increased prevalence of cleft lip and/ or cleft palate among epileptic patients
25. Congenital heart defects in live-born children of epileptic parents
26. Epilepsy among parents of children with facial clefts
27. Facial clefts and congenital heart defects in children of parents with epilepsy: genetic and environmental etiologic factors
28. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients
29. Significant anomalies in the anti-epileptic drug syndrome: comment (1982)
30. Hazards of fetal exposure to antiepileptic drugs: a preliminary report
31. Major malformations and minor anomalies in infants exposed to different antiepileptic drugs during pregnancy
32. Congenital malformations and anticonvulsant drugs
33. Hazards of fetal exposure to drug combinations
34. Maternal valproic acid and congenital neural tube defects
35. Valproic acid and spina bifida
36. In-utero exposure to valproate and neural tube defects
37. Anticonvulsant drugs in monotherapy. Effect on the fetus
38. The role of ultrasound in the early diagnosis of fetal structural defects following maternal anticonvulsant therapy
39. Congenital malformations associated with maternal use of valproic acid
40. Psychological disturbances and folic acid in chronic epileptic outpatients
41. Folate status and requirement in pregnancy
42. Folate status throughout pregnancy and in the postpartum period
43. Multiple congenital abnormalities resulting from transitory deficiency of pteroylglutamic acid during gestation in the rat
44. Effect of a folic acid antagonist, aminopterin, on fetal development and nucleic acid metabolism in the rat
45. Embryotoxicity of the folate antagonist methotrexate in rats and rabbits
46. Maternal folate deficiency and pregnancy wastage. II. Fetal malformation
47. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
48. Influence of folic acid on blood-phenytoin levels
49. Mechanism of teratogenicity of antiepileptic drugs. 2nd Report: maternal serum folic acid levels (abstr)
50. Counseling for epileptic women of childbearing age